Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver
Authors:
- 30 May 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 145 (5) , 591-603
Abstract
Objectives: Graft-vs-host disease (GVHD) is a donor T-cell-mediated disorder affecting the recipient’s skin, gastrointestinal tract, lungs, and liver. It complicates up to 70% of hematopoietic cell transplantation and is associated with high morbidity and mortality rates. Methods: An extensive review of the literature has been performed to include the most current consensus on the histopathologic diagnosis of gastrointestinal and liver GVHD. Results: In this review, we present an overview of GVHD, with emphasis on the histopathologic evaluation of gastrointestinal and liver specimens, including the most important differential diagnoses and possible pitfalls. Conclusions: Histopathologic examination remains the mainstay of diagnosis of gastrointestinal and liver GVHD and is interpreted in conjunction with clinical and laboratory data.Keywords
This publication has 59 references indexed in Scilit:
- Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortalityBlood, 2013
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host DiseaseNew England Journal of Medicine, 2012
- Risk factors for acute GVHD and survival after hematopoietic cell transplantationBlood, 2012
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaBlood, 2011
- Hematopoietic Stem Cell TransplantationA Global PerspectiveJAMA, 2010
- Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†Hepatology, 2010
- Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials NetworkTransplantation and Cellular Therapy, 2010
- Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials NetworkBlood, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- Ground-Glass, Polyglucosan-Like Hepatocellular Inclusions: A “New” Diagnostic EntityGastroenterology, 2006